{"hands_on_practices": [{"introduction": "This practice explores a critical aspect of *P. aeruginosa*'s virulence: its ability to acquire iron, an essential nutrient, from the host. In environments like the cystic fibrosis lung, iron is tightly bound by host proteins such as transferrin. This exercise will have you model the biochemical competition between *P. aeruginosa*'s high-affinity siderophore, pyoverdine, and human transferrin, allowing you to quantitatively understand how this bacterium thrives in an iron-limited environment [@problem_id:4670890].", "problem": "Pseudomonas aeruginosa secretes the siderophore pyoverdine (PVD) to acquire ferric iron from host proteins in the airway secretions of people with cystic fibrosis (CF). Consider a simplified, scientifically plausible model of CF sputum in which only two ligands compete for ferric iron: pyoverdine (PVD) secreted by Pseudomonas aeruginosa and human transferrin (Tf). Assume that each ligand forms a single dominant $1:1$ complex with ferric iron and that activities equal concentrations. The conditional $1:1$ association constants (at $\\mathrm{pH}\\ 7.0$ and ionic strength typical of CF sputum) for ferric iron binding are $K_{\\mathrm{pvd}} = 5.0 \\times 10^{22} \\ \\mathrm{M}^{-1}$ for pyoverdine and $K_{\\mathrm{tf}} = 2.0 \\times 10^{22} \\ \\mathrm{M}^{-1}$ for transferrin. The total concentrations are $[\\mathrm{Fe}]_{\\mathrm{tot}} = 1.0 \\times 10^{-6} \\ \\mathrm{M}$, $[\\mathrm{PVD}]_{\\mathrm{tot}} = 3.0 \\times 10^{-6} \\ \\mathrm{M}$, and $[\\mathrm{Tf}]_{\\mathrm{tot}} = 2.0 \\times 10^{-5} \\ \\mathrm{M}$. Assume a metal-limiting regime where $[\\mathrm{Fe}]_{\\mathrm{tot}} \\ll [\\mathrm{PVD}]_{\\mathrm{tot}}, [\\mathrm{Tf}]_{\\mathrm{tot}}$ so that free ligand concentrations are approximately equal to their total concentrations.\n\nUsing only the law of mass action and conservation of mass, derive from first principles an expression for the equilibrium fraction of total ferric iron bound by pyoverdine, and then compute its numerical value under the given conditions. Express your final answer as a dimensionless decimal and round to four significant figures.", "solution": "The problem describes a competitive binding equilibrium, a fundamental concept in chemistry and biology. The scenario of *Pseudomonas aeruginosa* acquiring iron in the cystic fibrosis lung environment is scientifically relevant and extensively studied. The provided association constants and concentrations are within plausible ranges for such a biological system. The problem is self-contained, providing all necessary data and a simplifying assumption to make the problem tractable without numerical root-finding. The goal is clearly defined and requires derivation from first principles, making it a well-posed and objective scientific problem. The assumption $[\\mathrm{Fe}]_{\\mathrm{tot}} \\ll [\\mathrm{PVD}]_{\\mathrm{tot}}$ is somewhat weak as $1.0 \\times 10^{-6}$ is one-third of $3.0 \\times 10^{-6}$, but it is an explicitly stated condition of the problem to guide the solution method, rather than a flaw. The problem is therefore deemed valid. A complete, reasoned solution follows.\n\nThe system involves two competing equilibrium reactions for the binding of ferric iron, which we denote as $\\mathrm{Fe}^{3+}$, by pyoverdine ($\\mathrm{PVD}$) and transferrin ($\\mathrm{Tf}$). We will use simplified notation where $[\\mathrm{Fe}]$ denotes the concentration of free ferric iron, $[\\mathrm{PVD}]$ and $[\\mathrm{Tf}]$ denote the concentrations of free ligands, and $[\\mathrm{FePVD}]$ and $[\\mathrm{FeTf}]$ denote the concentrations of the respective $1:1$ complexes.\n\nThe governing equilibrium reactions are:\n$$\n\\mathrm{Fe}^{3+} + \\mathrm{PVD} \\rightleftharpoons \\mathrm{FePVD}\n$$\n$$\n\\mathrm{Fe}^{3+} + \\mathrm{Tf} \\rightleftharpoons \\mathrm{FeTf}\n$$\nAccording to the law of mass action, the association constants are given by:\n$$\nK_{\\mathrm{pvd}} = \\frac{[\\mathrm{FePVD}]}{[\\mathrm{Fe}][\\mathrm{PVD}]} \\quad (1)\n$$\n$$\nK_{\\mathrm{tf}} = \\frac{[\\mathrm{FeTf}]}{[\\mathrm{Fe}][\\mathrm{Tf}]} \\quad (2)\n$$\nThe conservation of mass for total iron requires that the sum of the concentrations of all iron-containing species equals the total iron concentration:\n$$\n[\\mathrm{Fe}]_{\\mathrm{tot}} = [\\mathrm{Fe}] + [\\mathrm{FePVD}] + [\\mathrm{FeTf}] \\quad (3)\n$$\nOur goal is to derive an expression for the fraction of total ferric iron bound by pyoverdine, which we will call $F_{\\mathrm{pvd}}$:\n$$\nF_{\\mathrm{pvd}} = \\frac{[\\mathrm{FePVD}]}{[\\mathrm{Fe}]_{\\mathrm{tot}}} \\quad (4)\n$$\nFirst, we express the concentrations of the complexed species in terms of the free iron concentration, $[\\mathrm{Fe}]$, using equations $(1)$ and $(2)$:\n$$\n[\\mathrm{FePVD}] = K_{\\mathrm{pvd}}[\\mathrm{Fe}][\\mathrm{PVD}] \\quad (5)\n$$\n$$\n[\\mathrm{FeTf}] = K_{\\mathrm{tf}}[\\mathrm{Fe}][\\mathrm{Tf}] \\quad (6)\n$$\nNext, we substitute these expressions into the mass balance equation for iron, equation $(3)$:\n$$\n[\\mathrm{Fe}]_{\\mathrm{tot}} = [\\mathrm{Fe}] + K_{\\mathrm{pvd}}[\\mathrm{Fe}][\\mathrm{PVD}] + K_{\\mathrm{tf}}[\\mathrm{Fe}][\\mathrm{Tf}]\n$$\nFactoring out the free iron concentration, $[\\mathrm{Fe}]$, yields:\n$$\n[\\mathrm{Fe}]_{\\mathrm{tot}} = [\\mathrm{Fe}] \\left( 1 + K_{\\mathrm{pvd}}[\\mathrm{PVD}] + K_{\\mathrm{tf}}[\\mathrm{Tf}] \\right) \\quad (7)\n$$\nNow we can construct the expression for the desired fraction, $F_{\\mathrm{pvd}}$, by substituting equations $(5)$ and $(7)$ into the definition in equation $(4)$:\n$$\nF_{\\mathrm{pvd}} = \\frac{K_{\\mathrm{pvd}}[\\mathrm{Fe}][\\mathrm{PVD}]}{[\\mathrm{Fe}] \\left( 1 + K_{\\mathrm{pvd}}[\\mathrm{PVD}] + K_{\\mathrm{tf}}[\\mathrm{Tf}] \\right)}\n$$\nThe term $[\\mathrm{Fe}]$ cancels from the numerator and denominator, giving the general expression for the fraction of iron bound to PVD:\n$$\nF_{\\mathrm{pvd}} = \\frac{K_{\\mathrm{pvd}}[\\mathrm{PVD}]}{1 + K_{\\mathrm{pvd}}[\\mathrm{PVD}] + K_{\\mathrm{tf}}[\\mathrm{Tf}]} \\quad (8)\n$$\nThe problem specifies a metal-limiting regime where $[\\mathrm{Fe}]_{\\mathrm{tot}}$ is much smaller than the total ligand concentrations. This allows the approximation that the free ligand concentrations at equilibrium are nearly equal to their total concentrations:\n$$\n[\\mathrm{PVD}] \\approx [\\mathrm{PVD}]_{\\mathrm{tot}}\n$$\n$$\n[\\mathrm{Tf}] \\approx [\\mathrm{Tf}]_{\\mathrm{tot}}\n$$\nSubstituting these approximations into equation $(8)$:\n$$\nF_{\\mathrm{pvd}} \\approx \\frac{K_{\\mathrm{pvd}}[\\mathrm{PVD}]_{\\mathrm{tot}}}{1 + K_{\\mathrm{pvd}}[\\mathrm{PVD}]_{\\mathrm{tot}} + K_{\\mathrm{tf}}[\\mathrm{Tf}]_{\\mathrm{tot}}} \\quad (9)\n$$\nThis is the derived expression for the equilibrium fraction of total ferric iron bound by pyoverdine under the given assumptions.\n\nNow, we compute the numerical value. Let's calculate the products in the expression:\n$$\nK_{\\mathrm{pvd}}[\\mathrm{PVD}]_{\\mathrm{tot}} = (5.0 \\times 10^{22} \\ \\mathrm{M}^{-1}) \\times (3.0 \\times 10^{-6} \\ \\mathrm{M}) = 1.5 \\times 10^{17}\n$$\n$$\nK_{\\mathrm{tf}}[\\mathrm{Tf}]_{\\mathrm{tot}} = (2.0 \\times 10^{22} \\ \\mathrm{M}^{-1}) \\times (2.0 \\times 10^{-5} \\ \\mathrm{M}) = 4.0 \\times 10^{17}\n$$\nThe denominator is $1 + 1.5 \\times 10^{17} + 4.0 \\times 10^{17} = 1 + 5.5 \\times 10^{17}$. Because the term $1$ is negligible compared to $5.5 \\times 10^{17}$, which reflects the fact that very little iron remains free at equilibrium, we can simplify the expression in equation $(9)$:\n$$\nF_{\\mathrm{pvd}} \\approx \\frac{K_{\\mathrm{pvd}}[\\mathrm{PVD}]_{\\mathrm{tot}}}{K_{\\mathrm{pvd}}[\\mathrm{PVD}]_{\\mathrm{tot}} + K_{\\mathrm{tf}}[\\mathrm{Tf}]_{\\mathrm{tot}}}\n$$\nSubstituting the calculated values:\n$$\nF_{\\mathrm{pvd}} \\approx \\frac{1.5 \\times 10^{17}}{1.5 \\times 10^{17} + 4.0 \\times 10^{17}} = \\frac{1.5 \\times 10^{17}}{5.5 \\times 10^{17}}\n$$\n$$\nF_{\\mathrm{pvd}} \\approx \\frac{1.5}{5.5} = \\frac{3}{11}\n$$\nConverting this fraction to a decimal and rounding to four significant figures as required:\n$$\nF_{\\mathrm{pvd}} \\approx 0.272727... \\approx 0.2727\n$$\nThus, under the given conditions, approximately $27.27\\%$ of the total ferric iron is bound by pyoverdine.", "answer": "$$\n\\boxed{0.2727}\n$$", "id": "4670890"}, {"introduction": "Moving from pathogenesis to clinical management, this practice addresses the challenge of antibiotic resistance in *P. aeruginosa*. Accurate antibiotic susceptibility testing is crucial for guiding effective therapy. In this problem, you will step into the role of a clinical microbiologist evaluating the performance of an automated testing system against a reference method, learning to calculate key metrics like categorical agreement and error rates that ensure diagnostic reliability [@problem_id:4670909].", "problem": "An automated antimicrobial susceptibility testing system (System X) is evaluated against the reference broth microdilution method for clinical isolates of Pseudomonas aeruginosa. For each isolate–antibiotic pair, you are given the Minimum Inhibitory Concentration (MIC), in micrograms per milliliter, determined by the reference method and by System X. Use the Clinical and Laboratory Standards Institute (CLSI) breakpoints for Pseudomonas aeruginosa to classify each MIC into categorical results: Susceptible (S), Intermediate (I), or Resistant (R). Then compute the categorical agreement and error rates, and finally compute a composite penalized agreement score as defined below.\n\nFoundational definitions to use:\n- The Minimum Inhibitory Concentration (MIC) is the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism.\n- The Clinical and Laboratory Standards Institute (CLSI) sets MIC breakpoints that define interpretive categories: Susceptible (S), Intermediate (I), and Resistant (R) for organism–antibiotic pairs.\n- Categorical agreement (CA) is the proportion of isolate–antibiotic comparisons where System X and the reference method assign the same category (S, I, or R).\n- Very Major Error (VME) is when the reference is R and System X reports S. The VME rate is the number of VME divided by the number of reference R results.\n- Major Error (ME) is when the reference is S and System X reports R. The ME rate is the number of ME divided by the number of reference S results.\n- Minor Error (mE) is a discrepancy that involves the I category (S versus I or R versus I in either direction). The mE rate is the number of mE divided by the total number of isolate–antibiotic comparisons.\n\nCLSI breakpoints to apply:\n- Meropenem: Susceptible if MIC $\\leq 1$, Intermediate if MIC $= 2$, Resistant if MIC $\\geq 4$.\n- Ceftazidime: Susceptible if MIC $\\leq 8$, Intermediate if MIC $= 16$, Resistant if MIC $\\geq 32$.\n\nData: For each isolate $i \\in \\{1,\\dots,10\\}$, you are given four MIC values: reference meropenem, System X meropenem, reference ceftazidime, and System X ceftazidime.\n- Isolate $1$: meropenem (reference $0.5$, System X $1$); ceftazidime (reference $4$, System X $8$).\n- Isolate $2$: meropenem (reference $1$, System X $4$); ceftazidime (reference $8$, System X $32$).\n- Isolate $3$: meropenem (reference $2$, System X $1$); ceftazidime (reference $16$, System X $8$).\n- Isolate $4$: meropenem (reference $8$, System X $1$); ceftazidime (reference $64$, System X $8$).\n- Isolate $5$: meropenem (reference $4$, System X $4$); ceftazidime (reference $32$, System X $32$).\n- Isolate $6$: meropenem (reference $2$, System X $4$); ceftazidime (reference $16$, System X $32$).\n- Isolate $7$: meropenem (reference $0.5$, System X $2$); ceftazidime (reference $2$, System X $16$).\n- Isolate $8$: meropenem (reference $4$, System X $8$); ceftazidime (reference $32$, System X $64$).\n- Isolate $9$: meropenem (reference $0.25$, System X $0.5$); ceftazidime (reference $1$, System X $2$).\n- Isolate $10$: meropenem (reference $2$, System X $2$); ceftazidime (reference $16$, System X $16$).\n\nTasks:\n1. For each antibiotic separately, map each MIC to its category (S, I, or R) using the breakpoints, then determine for each isolate whether System X agrees with the reference, or commits a Very Major Error, Major Error, or Minor Error according to the definitions above.\n2. For each antibiotic, compute the categorical agreement (CA), Very Major Error rate (VME), Major Error rate (ME), and Minor Error rate (mE) using the denominators specified above.\n3. Compute micro-averaged rates across both antibiotics by pooling counts across meropenem and ceftazidime before forming the ratios (that is, compute pooled CA, VME, ME, and mE using the combined numerators and denominators across both antibiotics).\n4. Define a composite penalized agreement score\n$$Q \\equiv \\mathrm{CA}_{\\text{micro}} - 2\\,\\mathrm{VME}_{\\text{micro}} - 1\\,\\mathrm{ME}_{\\text{micro}} - 0.5\\,\\mathrm{mE}_{\\text{micro}}.$$\nReport the value of $Q$ as a dimensionless decimal rounded to four significant figures. Do not express the result as a percentage and do not include units.", "solution": "This problem requires a step-by-step analysis of antimicrobial susceptibility test data. We will first categorize each MIC value, then identify discrepancies, and finally calculate the required metrics and the composite score $Q$.\n\n### Step 1: Categorize MICs and Identify Errors\n\nWe apply the given CLSI breakpoints to the reference and System X MIC values for all 10 isolates and both antibiotics. An error is recorded for any isolate where the category from System X does not match the reference category.\n\n**Meropenem Breakpoints:** Susceptible (S) if MIC $\\leq 1$, Intermediate (I) if MIC $= 2$, Resistant (R) if MIC $\\geq 4$.\n\n| Isolate | Ref MIC | Ref Cat | SysX MIC | SysX Cat | Result |\n|:---:|:---:|:---:|:---:|:---:|:---|\n| 1 | 0.5 | S | 1 | S | Agreement (CA) |\n| 2 | 1 | S | 4 | R | **Major Error (ME)** |\n| 3 | 2 | I | 1 | S | **Minor Error (mE)** |\n| 4 | 8 | R | 1 | S | **Very Major Error (VME)** |\n| 5 | 4 | R | 4 | R | Agreement (CA) |\n| 6 | 2 | I | 4 | R | **Minor Error (mE)** |\n| 7 | 0.5 | S | 2 | I | **Minor Error (mE)** |\n| 8 | 4 | R | 8 | R | Agreement (CA) |\n| 9 | 0.25 | S | 0.5 | S | Agreement (CA) |\n| 10 | 2 | I | 2 | I | Agreement (CA) |\n\n**Ceftazidime Breakpoints:** Susceptible (S) if MIC $\\leq 8$, Intermediate (I) if MIC $= 16$, Resistant (R) if MIC $\\geq 32$.\n\n| Isolate | Ref MIC | Ref Cat | SysX MIC | SysX Cat | Result |\n|:---:|:---:|:---:|:---:|:---:|:---|\n| 1 | 4 | S | 8 | S | Agreement (CA) |\n| 2 | 8 | S | 32 | R | **Major Error (ME)** |\n| 3 | 16 | I | 8 | S | **Minor Error (mE)** |\n| 4 | 64 | R | 8 | S | **Very Major Error (VME)** |\n| 5 | 32 | R | 32 | R | Agreement (CA) |\n| 6 | 16 | I | 32 | R | **Minor Error (mE)** |\n| 7 | 2 | S | 16 | I | **Minor Error (mE)** |\n| 8 | 32 | R | 64 | R | Agreement (CA) |\n| 9 | 1 | S | 2 | S | Agreement (CA) |\n| 10 | 16 | I | 16 | I | Agreement (CA) |\n\n### Step 2: Compile Counts and Calculate Micro-Averaged Rates\n\nWe pool the counts from both antibiotics to get the totals needed for the micro-averaged rates. Total number of tests is $10 + 10 = 20$.\n\n-   **Total Categorical Agreements (CA):** $5$ (Mero) $+ 5$ (Cefta) $= 10$\n-   **Total Very Major Errors (VME):** $1$ (Mero) $+ 1$ (Cefta) $= 2$\n-   **Total Major Errors (ME):** $1$ (Mero) $+ 1$ (Cefta) $= 2$\n-   **Total Minor Errors (mE):** $3$ (Mero) $+ 3$ (Cefta) $= 6$\n\nNext, we count the total number of reference results in each category to serve as denominators for the error rates.\n-   **Total Reference Susceptible (Ref S):** $4$ (Mero) $+ 4$ (Cefta) $= 8$\n-   **Total Reference Resistant (Ref R):** $3$ (Mero) $+ 3$ (Cefta) $= 6$\n\nNow we can calculate the micro-averaged rates as defined in the problem:\n-   $\\mathrm{CA}_{\\text{micro}} = \\frac{\\text{Total CA}}{\\text{Total Tests}} = \\frac{10}{20} = 0.5$\n-   $\\mathrm{VME}_{\\text{micro}} = \\frac{\\text{Total VME}}{\\text{Total Ref R}} = \\frac{2}{6} = \\frac{1}{3}$\n-   $\\mathrm{ME}_{\\text{micro}} = \\frac{\\text{Total ME}}{\\text{Total Ref S}} = \\frac{2}{8} = 0.25$\n-   $\\mathrm{mE}_{\\text{micro}} = \\frac{\\text{Total mE}}{\\text{Total Tests}} = \\frac{6}{20} = 0.3$\n\n### Step 3: Compute the Composite Penalized Agreement Score ($Q$)\n\nWe use the defined formula and substitute the calculated micro-averaged rates:\n$$Q \\equiv \\mathrm{CA}_{\\text{micro}} - 2\\,\\mathrm{VME}_{\\text{micro}} - 1\\,\\mathrm{ME}_{\\text{micro}} - 0.5\\,\\mathrm{mE}_{\\text{micro}}$$\n$$Q = 0.5 - 2\\left(\\frac{1}{3}\\right) - 1(0.25) - 0.5(0.3)$$\n$$Q = 0.5 - \\frac{2}{3} - 0.25 - 0.15$$\n$$Q = (0.5 - 0.25 - 0.15) - \\frac{2}{3}$$\n$$Q = 0.1 - \\frac{2}{3}$$\n$$Q = \\frac{1}{10} - \\frac{2}{3} = \\frac{3}{30} - \\frac{20}{30} = -\\frac{17}{30}$$\nAs a decimal, this is approximately $-0.56666...$.\nRounding to four significant figures, the final score is:\n$$Q = -0.5667$$", "answer": "$$\\boxed{-0.5667}$$", "id": "4670909"}, {"introduction": "Effectively treating multidrug-resistant *P. aeruginosa* often requires using antibiotics in combination. This exercise introduces the concept of synergy, where two drugs working together are more effective than either alone. You will calculate the Fractional Inhibitory Concentration Index (FICI), a key metric used in microbiology to quantify and classify drug interactions, providing insight into how potential combination therapies are evaluated [@problem_id:4670936].", "problem": "A clinical isolate of Pseudomonas aeruginosa from a cystic fibrosis sputum sample exhibits biofilm-associated tolerance. In a standardized broth microdilution assay, the Minimum Inhibitory Concentration (MIC) of ceftazidime is $8$ $\\mathrm{\\mu g/mL}$ and the MIC of tobramycin is $2$ $\\mathrm{\\mu g/mL}$. In a checkerboard assay performed to evaluate two-drug interactions, the well that shows complete inhibition of visible growth contains a combination in which the Fractional Inhibitory Concentration (FIC) contributions, empirically derived from the two-drug dilution matrix, are $0.25$ for ceftazidime and $0.125$ for tobramycin. Using these data and the standard interpretation framework for the Fractional Inhibitory Concentration Index (FICI), compute the FICI for the observed inhibitory well. Round your final FICI to three significant figures. Then, based on the conventional ranges, classify the interaction as synergy if $FICI \\leq 0.5$, additivity if $0.5  FICI \\leq 1$, indifference if $1  FICI \\leq 4$, or antagonism if $FICI  4$. Express only the FICI as your final answer (dimensionless).", "solution": "The problem is scientifically and mathematically well-posed, providing all necessary information for a direct calculation. It concerns the evaluation of a two-drug combination therapy against a clinical isolate of *Pseudomonas aeruginosa*, a standard procedure in medical microbiology.\n\nThe central concept is the Fractional Inhibitory Concentration Index (FICI), a dimensionless quantity used to quantify the interaction between two antimicrobial agents. The FICI is calculated by summing the Fractional Inhibitory Concentrations (FICs) of each drug in the combination that results in the inhibition of microbial growth.\n\nThe FIC for a given drug (e.g., drug A) is defined as the ratio of its concentration in an inhibitory combination ($C_A$) to its Minimum Inhibitory Concentration (MIC) when used alone ($MIC_A$):\n$$FIC_A = \\frac{C_A}{MIC_A}$$\nSimilarly, for a second drug (drug B):\n$$FIC_B = \\frac{C_B}{MIC_B}$$\n\nThe FICI is the sum of these individual FIC values:\n$$FICI = FIC_A + FIC_B$$\n\nThe problem provides the following data:\n-   Minimum Inhibitory Concentration of ceftazidime, $MIC_{ceftazidime} = 8 \\mathrm{\\mu g/mL}$.\n-   Minimum Inhibitory Concentration of tobramycin, $MIC_{tobramycin} = 2 \\mathrm{\\mu g/mL}$.\n-   Fractional Inhibitory Concentration of ceftazidime in the combination, $FIC_{ceftazidime} = 0.25$.\n-   Fractional Inhibitory Concentration of tobramycin in the combination, $FIC_{tobramycin} = 0.125$.\n\nNote that the MIC values, while provided for context and realism, are not required for the calculation, as the FIC values are given directly.\n\nWe can now compute the FICI by substituting the given FIC values into the defining equation:\n$$FICI = FIC_{ceftazidime} + FIC_{tobramycin}$$\n$$FICI = 0.25 + 0.125$$\n$$FICI = 0.375$$\n\nThe problem requires the final answer to be rounded to three significant figures. The calculated value $0.375$ already contains exactly three significant figures (the digits $3$, $7$, and $5$), so no further rounding is necessary.\n\nThe final step described in the problem, though not part of the final answer to be reported, is to classify the interaction. The given criteria are: synergy if $FICI \\leq 0.5$, additivity if $0.5  FICI \\leq 1$, indifference if $1  FICI \\leq 4$, and antagonism if $FICI  4$.\nSince our calculated value is $FICI = 0.375$, and $0.375 \\leq 0.5$, the interaction between ceftazidime and tobramycin in this specific well is classified as **synergy**.\n\nThe required final answer is the numerical value of the FICI.", "answer": "$$\\boxed{0.375}$$", "id": "4670936"}]}